Edward Chao

Title(s)	Clinical Professor, Medicine
School	Vc-health Sciences-schools
Address	9500 Gilman Drive # La Jolla CA 92093
vCard	Download vCard

Biography

Education and Training

University of New England College of Osteopathic Medicine, Biddeford, ME	DO	06/2002	Osteopathic Medicine
Loma Linda University, Loma Linda, CA		06/2005	Internal Medicine Residency
University of California, San Diego, San Diego, CA		06/2009	Endocrinology

Awards and Honors

UCSD School of Medicine

2010

Medicine 401 Excellence in Teaching Award

Overview

In The News

	'Smart Tattoos' Could Someday Monitor Your Vitals — No Batteries Required (07/27/2019)
	New Tattoo Sensor Could Be The Future Of Glucose Monitoring For Diabetes Patients05 (05/14/2018)
	Clinical Trial Tests Tattoo Sensor as Needleless Glucose Monitor for Diabetes Patients (04/23/2018)
	Clinical Trial Tests Tattoo Sensor as Needleless Glucose Monitor for Diabetes Patients (04/19/2018)
	Benefits, Risks of SGLT2 Inhibitors Explored at Session (06/16/2014)

Research

Research Activities and Funding

Studying the Effectiveness of Non-Invasive Glucose Sensors in Patients with Diabetes: The SENSOR Study
NIH UL1TR001442
Role: Principal Investigator
Description: The goal of this study is to examine the accuracy, reliability, feasibility, and validity of a wearable, needle-free glucose sensor, compared with self-monitoring of blood glucose (SMBG) readings from a glucometer, in patients with diabetes mellitus.

ORNG Applications

Featured Publications

Bibliographic

Publications

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.

Altmetrics Details

PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.

Collaboratively Designing an App for a More Personalized, Community-Endorsed Continuous Glucose Monitoring Onboarding Experience: An Early Study. J Diabetes Sci Technol. 2024 Jan; 18(1):14-21. Chao EC, Zhang M, Houle MA, Rataj H. PMID: 37978817; PMCID: PMC10899834.

View in: PubMed Mentions: 1 Fields:
End Endocrinology
Translation:Humans
Zooming In, Then Out: Why We Must Apply Human-Centered Design to Transform Diabetes Technology. J Diabetes Sci Technol. 2024 Jan; 18(1):193-195. Chao EC. PMID: 37970832; PMCID: PMC10899855.

View in: PubMed Mentions: Fields:
End Endocrinology
Translation:Humans
A smoothed corrected score approach for proportional hazards model with misclassified discretized covariates induced by error-contaminated continuous time-dependent exposure. Biometrics. 2023 03; 79(1):437-448. Song X, Chao EC, Wang CY. PMID: 34694632; PMCID: PMC9399755.

View in: PubMed Mentions: Fields:
Sta Statistics as Topic
SGLT-2 Inhibitors: A New Mechanism for Glycemic Control. Clin Diabetes. 2014 Jan; 32(1):4-11. Chao EC. PMID: 26246672; PMCID: PMC4521423.

View in: PubMed Mentions: 55
Dapagliflozin: an evidence-based review of its potential in the treatment of type-2 diabetes. Core Evid. 2012; 7:21-8. Chao EC. PMID: 22701099; PMCID: PMC3373192.

View in: PubMed Mentions: 3
Dapagliflozin--redefining treatment of T2DM? Nat Rev Endocrinol. 2011 Oct 11; 7(12):696-7. Chao EC. PMID: 21989092.

View in: PubMed Mentions: Fields:
End Endocrinology
Translation:Humans
A paradigm shift in diabetes therapy--dapagliflozin and other SGLT2 inhibitors. Discov Med. 2011 Mar; 11(58):255-63. Chao EC. PMID: 21447284.

View in: PubMed Mentions: 9 Fields:
Med Medicine (General)
Translation:Humans
SGLT2 inhibition--a novel strategy for diabetes treatment. Nat Rev Drug Discov. 2010 Jul; 9(7):551-9. Chao EC, Henry RR. PMID: 20508640.

View in: PubMed Mentions: 223 Fields:
Dru Drug Therapy Pha Pharmacology
Translation:Humans Animals